Cholesterol Lowering in the Elderly Population

Authors:
  • JCJames I. Cleeman
    James I. Cleeman
  • BRBasil M. Rifkind
    Basil M. Rifkind
  • LKLewis H. Kuller
    Lewis H. Kuller

Abstract
The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.

This publication has 37 references indexed in Scilit: